Medical Bionic Implant/Artificial Organs Market Research Report – Forecast to 2027

Medical Bionic Implant/Artificial Organs Market Research Report: By Technology (Mechanical, Electronic Bionics), Product (Vision, Ear, Orthopedic, Heart, Neural/Brain), Fixation (Implantable, Externally Worn), End-User -Forecast Till 2027

ID: MRFR/MED/4593-HCR | February 2021 | Region: Global | 100 pages         

Medical Bionic Implant Artificial Organs Market Speak to Analyst Request a Free Sample

Medical Bionic Implant/Artificial Organs Market Overview


According to the Medical Bionic Implant Market is expected to hold a CAGR of 7% during the forecast period. Artificial organs and implants are types of special devices made to carry out the implantation of organs in the human body. It is mainly used so that the organs can function or intimate the original organ. Bionics is divided into parts and are biology and electronics. Medical bionics are substituted robotic versions of the body parts that are damaged.


Organ transplants become necessary when an organ of a body gets damaged due to any reason. However, there are also chances that the brogan transplant will not succeed as sometimes the body rejects the organ transplant. It is a substance introduced in the body to improve the body and make it function like before. The most developed bionics organs, heart and kidney and the most developed medical bionics, are pacemaker and cochlear.


Covid-19 analysis


Pandemic affected most of the business, but the healthcare sector gained growth. The Healthcare sector is the one sector that improved its marketplace. Due to the virus spread, people got dependent on the healthcare sector for treatment, which positively impacted the market. But due to the constant attention to the covid patients, other patients got ignored and didn't get the required treatment which is a major issue for the market growth. When the manufacturers and production facilities were ordered to closed and people were told to stay inside to lessen the spread, the shutdown of markets and quarantine orders by the government impacted the market negatively.


Chief Factors Existing In The Market 



  • Key drivers


Currently, the market is driven by the rising number of patients in need of organ transplantation. However, the transplant is not possible for everyone as the number of donors is very less than the number of patients. Continuous advancement in technology in the healthcare sector like equipment, treatment, and diagnosis boosts the market growth. The public is getting aware of several diseases and treatments, and advancement in the Artificial Organs Market procedure is helping the market to gain the highlight. The development of 3D printers in the Medical Bionic Implant/Artificial Organs Market also propels the market to grow in the forecast period. The increasing cases of accidents that lead to organ damage and organ transplant are the major growth factor for the market. The growing eye diseases with regulatory framework is also gaining market growth. Due to age-related issues and aging factors, people are experiencing organ failure enhancing the market growth.



  • Market challenges


The less number of donors and growing number of transplant patients is a huge challenge for the market to overcome. Although the number of patients increases, the advanced technology has still not made each transplant successful, due to which the Medical Bionic Implant/Artificial Organs Market is still facing several obstacles.



  • Market opportunities


Rapid technological advancement and government initiatives for healthcare are accelerating the market, forming a new opportunity for the Medical Bionic Implant Market Share. People getting more aware of their health and getting them check-ups once in a while also creates ample opportunity for the market.



  • Market restraints


The drivers are accelerating the market, but with the acceleration, several factors are also restraining the market from further growth. The drawbacks of holding the market are the high cost of the devices no certain reimbursement. The development cost is high, and with that, fewer experts doctors for such challenging roles is less, which is also negatively affecting the market growth.


Cumulative Evaluation Of The Market


The cumulative evaluation of the market shows various research done in the Medical Bionic Implant/Artificial Organs Market to develop the overall marketplace. Different segments like drivers and opportunities are accelerating the market and forming new ways for the new key players who are keen to invest in it. However, the key players must know about the restraints and challenges of the market to tackle them and try to overcome them as soon as possible to register a high growth rate in the forecast period. The impact of COVID is also mentioned in the evaluation of the Medical Bionic Implant Market Outlook to give the market a new form and depict that the market will grow further in the future.


Market segmentation



  • By technology


The market is bifurcated into Mechanical and Electronic Bionics based on the technology segment. Both segments make the market grow and contribute to the Medical Bionic Implant Market Value.



  • By-products


Based on the segment product, the Medical Bionic Implant/Artificial Organs Market is classified into Vision, Ear, Orthopedic, Heart, Neural/Brain. The Vision bionics has further been divided into the bionic eye. The bionic ear segment is classified into the cochlear implant and bone-anchored hearing aid. Orthopedic bionics are segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. Sub-segments of the bionic leg include bionic knees and bionic feet. Electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are segmented into pacemakers, total artificial heart, ventricular assist device, an artificial heart valve. The pacemaker has an implantable cardiac pacemaker and an external pacemaker. The sub-segments of the artificial heart valve include the mechanical heart valve and tissue heart valve. Neural/brain bionics of the market are divided into deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators and improve the Medical Bionic Implant Market Size.



  • By fixation


The fixation of the Medical Bionic Implant/Artificial Organs Market is segregated into Implantable and Externally Worn. Each segment variable is pushing the market forward and making the market grow to get a place in the global marketplace.


By End-User


The medical bionic implant/artificial organs market is segmented into hospitals and clinics, research and academic institutes, and others.


Regional analysis


The Medical Bionic Implant/Artificial Organs Market is studied in America, Asia, Pacific, Europe, the Middle East, Africa, and other parts. America is experiencing a high growth rate due to the presence of major key players and the introduction of advanced medical bionic equipment. Europe is dominating the market in the second place owing to the government's support in the region towards the development of the region and expenditure for research. Also, due to the rising cases of organ failures and other complications. Due to the increasing number of patients, rising demand for advanced treatment, healthcare sector development, growth in healthcare in the various Asian region is increasing, which directly accelerates the market growth. The Middle East and Africa are not showing the required growth as the region lacks technical knowledge and is not developing. Due to the poor medical facilities in the region, the market is lacking growth region. Other regions are showcasing significant growth and are expected to increase the CAGr of the market. The Medical Bionic Implant Market Analysis shows the market's growth in different regions.


Competitive Intensity Within The Industry 


Several key players are investing in the Medical Bionic Implant/Artificial Organs Market is expecting the market to grow in the forecast period. The Market development is based on the strategies don by the prominent players for market growth. The report consists of several details about the competitor. Other than that, that are many more details depicted in the report by the competitors are market production, market dominance, finance, investment, profit, and others. The key players are expected to improve the market value with several techniques. The competitive intensity between the prominent market investors will have a positive impact. The major key payers those are Medical Bionic Implant Market Growth are



  • Aleva Neurotherapeutics S.A. Switzerland

  •  Biocontrol Medical Israel

  •  Biomet, Inc. U.S.

  • Boston Scientific Corporation U.S.

  •  Cochlear Ltd. (Australia), Cyberonics, Inc. U.S.

  •  Ekso Bionics U.S.

  •  LivaNova PLC U.K.

  •  Medtronic, Inc. U.S.

  •  NeuroPace, Inc. U.S.

  • Orthofix International N.V. The Netherlands

  •  Ossur Iceland

  •  Second Sight Medical Products, Inc. U.S.

  •  St. Jude Medical, Inc. (U.S.).


Recent development 



  • The first pig to human transplant reported its success for the operation two months ago, but the patient David bennet Sr. at the age of 57, died for unknown reasons. The pig heart transplant needs more improvement.

  • Cyber firm Kaspersky has become one of the first organizations in the world to develop and implement a security policy covering the use of bionic devices and other forms of human augmentation.


Report Overview



  • The report provides research that is advanced and formative. The data mentioned in the report are made with proper research regarding the Medical Bionic Implant Market Trends. The report also contains details about the market segmentation and how they impact the market's growth in the forecast period. Covid 19 impact, drivers, restraints, highlights of the prominent key players and recent development happening in the market is predicted in the Medical Bionic Implant/Artificial Organs Market report.


Key industrial segments


By technology



  • Mechanical

  • Electronic Bionics


By-products



  • Vision

  • Ear

  •  Orthopedic

  •  Heart

  •  Neural/Brain


By fixation



  • Implantable

  • Externally Worn


By end-user



  • Hospitals

  • Clinics

  • Research and Academic Institutes



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.0% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Product, Fixation, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Technological advancements
  • Increasing accidents and injuries
  • Improving regulatory framework
  • Increasing government assistance Increasing prevalence of eye diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Medical Bionic Implant/Artificial Organs Market is projected to grow at a 7.0% CAGR between 2018-2023.

    The Americas is expected to lead the Medical Bionic Implant/Artificial Organs Market.

    Improving regulatory framework and increasing injuries and accidents are adding market growth.

    High cost and poor healthcare system may limit market growth.

    Different strategies used by market players to create a dominance in the Medical Bionic Implant/Artificial Organs Market include mergers and acquisitions, collaborations, product launches, and strategic alliances.